Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with intermediate- or high-risk prostate cancer, confirmed by a laboratory test on tissue samples.
- People whose PSA levels have risen on more than one test to above 0.2 ng/mL but no higher than 1.0 ng/mL after having their prostate surgically removed (this is called biochemical recurrence).
- People who are generally active and able to carry out daily activities with little or no limitation (rated 0 or 1 on a standard health scale used by doctors).
- People whose recent blood test results (within the last 6 months) show healthy enough levels of infection-fighting cells, platelets, and red blood cells.
- People whose recent kidney function test results (within the last 6 months) fall within an acceptable range.
- People whose recent liver function test results (within the last 6 months) fall within an acceptable range.
Who may not be able to join:
- People who have a visible or measurable returning tumour in the area where the prostate was removed.
- People whose cancer has spread to distant parts of the body (distant metastasis).
- People whose cancer has spread to lymph nodes in the pelvis.
- People who have previously had radiation treatment to the pelvic area.
- People who have previously been treated for prostate cancer using cryotherapy (freezing the tumour) or brachytherapy (internal radiation).
- People who have had a second, separate type of cancer, other than skin or thyroid cancer.
- People who have another serious health condition alongside their prostate cancer (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Young Seok Kim, M.D., Ph.D., Asan Medical Center
Phone: 82 2 3010 5614
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Biochemical recurrence-free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.